首页 | 本学科首页   官方微博 | 高级检索  
   检索      


In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma
Authors:G Di Giacomo  A Lentini  S Beninati  M Piacentini  C Rodolfo
Institution:(1) GE Healthcare, Medical Diagnostics Discovery, Hammersmith Imanet Ltd, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK;(2) GE Healthcare, Medical Diagnostics Discovery, Nycoveien 2, 0401 Oslo, Norway;(3) GE Healthcare, Medical Diagnostics, The Grove Centre, Amersham, HP7 9LL, UK;(4) Present address: Institute of Nuclear Medicine, University College London, University College London Hospitals NHS Trust, 235 Euston Road, London, NW1 2BU, UK
Abstract:Three strategies for chemoselective labeling of RGD peptides with 18F have been compared. Aminooxy 18F]fluorobenzaldehyde conjugation provided 40 ± 12% decay-corrected radiochemical yield using a fully automated method. An one-pot protocol for ‘click labeling’ of the RGD scaffold with 2-18F]fluoroethylazide afforded 47 ± 8% decay-corrected radiochemical yield. Attempted conjugation with 3-18F]fluoropropanethiol led to extensive decomposition and was therefore found unsuitable for labeling of the RGD peptide investigated. The results suggest that ‘click labeling’ of RGD peptides provides an attractive alternative to aminooxy aldehyde condensation, however, 2-18F]-fluoroethylazide may be too small to allow separation of large 18F-labeled RGD peptides from their precursors.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号